Related Experiment Videos
Community-acquired pneumonia: an update
1Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA.
Abstract:
Despite the discovery of new pathogens and the evolving problem of antibiotic resistance, the basic trends in community-acquired pneumonia remain remarkably constant. This article reviews the common pathogens, new pathogens, their clinical presentations, the diagnostic workup, the decision to hospitalize, antibiotic resistance, and antibiotic choices.
Insights
Community-acquired pneumonia trends are constant despite new pathogens and antibiotic resistance. This review covers common and new pathogens, diagnosis, hospitalization decisions, and antibiotic strategies for pneumonia.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Community-acquired pneumonia (CAP) remains a significant global health concern.
- Emerging pathogens and increasing antibiotic resistance complicate CAP management.
- Understanding persistent trends in CAP is crucial for effective treatment.
Purpose of the Study:
- To review the consistent epidemiological trends of community-acquired pneumonia.
- To discuss common and novel pathogens implicated in CAP.
- To outline current diagnostic and therapeutic strategies for CAP.
Main Methods:
- Literature review of community-acquired pneumonia epidemiology.
- Analysis of clinical presentations and diagnostic workup for CAP.
- Evaluation of antibiotic resistance patterns and treatment guidelines.
Main Results:
- Core trends in CAP pathogens and clinical outcomes remain stable.
- Antibiotic resistance poses an ongoing challenge in CAP treatment.
- Evidence-based guidelines inform hospitalization decisions and antibiotic selection.
Conclusions:
- Despite evolving challenges, fundamental aspects of CAP management persist.
- Continuous monitoring of pathogens and resistance is essential.
- Optimized diagnostic and therapeutic approaches improve CAP outcomes.